Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma

Heike Voigt1, Roland Houben, David Schrama

  • 1Department of Dermatology, Julius Maximilians University, Würzburg, Germany. Voigt_H@klinik.uni-wuerzburg.de

Abstract

Insights

In the B16 melanoma model, tumor cell CD147 (Cluster of Differentiation 147) did not significantly impact matrix metalloproteinase (MMP) induction in stromal cells. This suggests CD147 is not crucial for MMP regulation in this specific murine cancer model.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • CD147 (Cluster of Differentiation 147) on human tumor cells induces matrix metalloproteinases (MMPs) by stromal cells.
  • Evidence for this mechanism in murine models is lacking.

Purpose of the Study:

  • To investigate the role of CD147 in MMP induction within the murine B16 melanoma model.
  • To determine if CD147 expression on tumor cells influences MMP expression by associated stromal cells.

Main Methods:

  • Stable knockdown of CD147 in B16 melanoma cell lines.
  • In vivo validation of CD147 knockdown using immunohistochemistry.
  • In vitro coculture experiments with melanoma cells and fibroblast cell lines to assess MMP expression.

Main Results:

  • CD147 knockdown remained stable in vivo.
  • No significant differences in MMP-2, MMP-9, or MT1-MMP expression were observed between CD147-positive and CD147-knockdown tumors.
  • In vitro, B16 melanoma cells (both CD147-positive and knockdown) did not alter MMP-2 or MMP-9 expression by fibroblasts.

Conclusions:

  • CD147 expression on tumor cells is not critical for the induction of MMP-2, MMP-9, and MT1-MMP in tumor-associated stromal cells within the murine B16 melanoma model.
  • These findings contrast with observations in human systems, highlighting model-specific differences.